The Diagnostic Specialty Enzymes Market was valued at US$ 1.0 billion in 2022 and is projected to grow at a CAGR of 6.9% from ...

Pancreatic cancer is one of the deadliest forms of cancer, largely because it’s so difficult to catch early. By the time it’s ...

The global cell based assays market was projected to attain US$ 20.2 billion in 2023. It is anticipated to garner a 6.4% CAGR ...

The global nebulizers market was valued at US$ 1 billion in 2020. It is estimated to expand at a CAGR of 6.6% from 2021 to ...

The Inactivated Vaccines Market was valued at US$ 40.6 billion in 2023 and is projected to grow at a CAGR of 5.7% from 2024 ...

The global polyclonal antibody market is poised for significant expansion in the coming decade, driven by increasing ...

The global regenerative dentistry market is set for substantial expansion, driven by advancements in cell and molecular ...

The global defibrillator market was valued at US$ 7.2 billion in 2021 and is estimated to expand at a compound annual growth ...

Aging has long been accepted as an inevitable process, but what if we could measure the factors that accelerate it—and do ...

Ayurveda women's health market was valued at US$ 3.6 billion in 2023 and is projected to expand at a 6.3% CAGR from 2024 to 2034, reaching US$ 7.2 billion by 2034. Growing awareness of Ayurvedic ...

Annual ResultsBIOVERSYS ANNOUNCES REPORTING DATE FOR FULL-YEAR 2024 FINANCIAL RESULTS AND EVENT DETAILS 14.03.2025 / 07:00 CET/CESTBasel, Switzerland. March 14, 2025, 7am CETBioVersys AG (SIX: BIOV), ...

Panthera, the UK’s largest SMO (Site Management Organisation), has recently signed two clinical trial contracts worth over £10 million each. These trials for international pharma companies involve ...